Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Anticoagulant Reversal”

33 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 33 results

Testing effectiveness (Phase 2)WithdrawnNCT04794348
What this trial is testing

Clinical Trial Assessing Non-Inferiority of Freeze Dried Plasma to Fresh Frozen Plasma in Reversing Warfarin

Who this might be right for
Anticoagulant Reversal
Vascular Solutions LLC
Not applicableStudy completedNCT03254147
What this trial is testing

Medical Need of OAC Reversal

Who this might be right for
Atrial Fibrillation
Boehringer Ingelheim 53,969
Large-scale testing (Phase 3)Study completedNCT02329327
What this trial is testing

A Study in Participants With Acute Major Bleeding to Evaluate the Ability of Andexanet Alfa to Reverse the Anticoagulation Effect of Direct and Indirect Oral Anticoagulants (Extension Study)

Who this might be right for
Bleeding
Alexion Pharmaceuticals, Inc. 479
Not applicableUnknownNCT02745054
What this trial is testing

Safety of Oral Anticoagulants Registry

Who this might be right for
Blood Coagulation
Hospital Quality Foundation 1,500
Testing effectiveness (Phase 2)Study completedNCT02206087
What this trial is testing

Evaluation of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects of PER977 Following Heparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 60
Large-scale testing (Phase 3)Study completedNCT02815670
What this trial is testing

Reversal Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Large-scale testing (Phase 3)Study completedNCT00168077
What this trial is testing

Prothrombin Complex Concentrate for Anticoagulant Reversal

Who this might be right for
Acquired Coagulation Factor Deficiency
CSL Behring 40
Large-scale testing (Phase 3)Study completedNCT03343704
What this trial is testing

This Study Looks at the Effects of Idarucizumab in Patients Who Take Dabigatran and Need Emergency Surgery or Are Bleeding

Who this might be right for
Hemorrhage
Boehringer Ingelheim 19
Testing effectiveness (Phase 2)Study completedNCT02206100
What this trial is testing

PK and PD of Single, Escalating Doses of PER977 Following Enoxaparin

Who this might be right for
Healthy
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 40
Testing effectiveness (Phase 2)UnknownNCT02463591
What this trial is testing

Reversal of Dabigatran With Prothrombin Complex Concentrate

Who this might be right for
Drug Action Reversal
University Medical Center Groningen 12
Not applicableWithdrawnNCT03537521
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists (RADOA). Focus on New Antidots

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien
Large-scale testing (Phase 3)Study completedNCT02831660
What this trial is testing

CU Programme of Idarucizumab for Japanese Patients

Who this might be right for
Hemorrhage
Boehringer Ingelheim 1
Post-approval studies (Phase 4)Study completedNCT03140631
What this trial is testing

Use of Protamine for Heparin Reversal After Catheter Ablation of Atrial Fibrillation

Who this might be right for
Atrial FibrillationCatheter Ablation
University of Michigan 153
Large-scale testing (Phase 3)Study completedNCT02740335
What this trial is testing

Study of Octaplex, a Four-factor Prothrombin Complex Concentrate (4F-PCC) and Beriplex® P/N (Kcentra) for the Reversal of Vitamin K Antagonist (VKA) Induced Anticoagulation in Patients Needing Urgent Surgery With Significant Bleeding Risk.

Who this might be right for
Significant Bleeding Risk
Octapharma 208
Early research (Phase 1)Ended earlyNCT00770718
What this trial is testing

Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage

Who this might be right for
Intracranial Hemorrhage
University of Utah 2
Early research (Phase 1)Study completedNCT01826266
What this trial is testing

Effects of a Double-Blind, Single Dose of PER977 Administered Alone, and Following a Single Dose of Edoxaban

Who this might be right for
Anticoagulant ReversalReversal of Edoxaban Induced Anticoagulation
Perosphere Pharmaceuticals Inc, a wholly owned subsidiary of AMAG Pharmaceuticals, Inc. 83
Large-scale testing (Phase 3)Study completedNCT02104947
What this trial is testing

Reversal of Dabigatran Anticoagulant Effect With Idarucizumab

Who this might be right for
Hemorrhage
Boehringer Ingelheim 503
Not applicableStudy completedNCT01722786
What this trial is testing

Reversal Agent Use in Patients Treated With Direct Oral Anticoagulants or Vitamin K Antagonists

Who this might be right for
Severe BleedingUrgent Surgery
Cardioangiologisches Centrum Bethanien 272
Large-scale testing (Phase 3)Study completedNCT00708435
What this trial is testing

Efficacy and Safety Study of BERIPLEX® P/N (Kcentra) Compared With Plasma in Patients With Acute Major Bleeding Caused by Anticoagulant Therapy

Who this might be right for
Blood Coagulation DisordersAcute Major Bleeding
CSL Behring 216
Post-approval studies (Phase 4)UnknownNCT01478282
What this trial is testing

Reversal of the Antithrombotic Action of New Oral Anticoagulants

Who this might be right for
ThrombosisAnticoagulant-induced BleedingAnticoagulant Overdosage+1 more
Gines Escolar 10
Load More Results